These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 16708302

  • 21. Comparison of CYFRA 21-1 and tissue polypeptide specific antigen (TPS) for detecting nasopharyngeal carcinoma.
    Tai CJ, Liu FY, Liang JA, Yang SN, Tsai MH, Kao CH.
    Anticancer Res; 2002; 22(6B):3793-6. PubMed ID: 12552995
    [Abstract] [Full Text] [Related]

  • 22. Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients.
    Li Y, Tang ZY, Tian B, Ye SL, Qin LX, Xue Q, Sun RX.
    J Cancer Res Clin Oncol; 2006 Aug; 132(8):515-20. PubMed ID: 16788845
    [Abstract] [Full Text] [Related]

  • 23. Cytokeratin fragment 19 (CYFRA 21-1) in healthy smokers.
    Kao CH, Hsieh JF, Ho YJ, Tsai SC, Lee JK.
    Anticancer Res; 1999 Aug; 19(5C):4545-6. PubMed ID: 10650808
    [Abstract] [Full Text] [Related]

  • 24. [A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma].
    Ychou M, Khemissa-Akouz F, Kramar A, Senesse P, Grenier J.
    Bull Cancer; 2001 Oct; 88(10):1023-7. PubMed ID: 11713038
    [Abstract] [Full Text] [Related]

  • 25. CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA.
    Molina R, Filella X, Augé JM, Bosch E, Torne A, Pahisa J, Lejarcegui JA, Rovirosa A, Mellado B, Ordi J, Biete A.
    Anticancer Res; 2005 Oct; 25(3A):1765-71. PubMed ID: 16033097
    [Abstract] [Full Text] [Related]

  • 26. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
    Zhong LP, Zhang CP, Zheng JW, Li J, Chen WT, Zhang ZY.
    Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
    [Abstract] [Full Text] [Related]

  • 27. Predictive Value of Serum CYFRA 21-1 and CK19-2G2 for Tumor Aggressiveness and Overall Survival in Hepatitis C-Related Hepatocellular Carcinoma Among Egyptians: A Prospective Study.
    Taher MY, Hassouna EM, El-Hadidi AS, El-Aassar OS, Bakosh MF.
    J Gastrointest Cancer; 2024 Jun; 55(2):749-758. PubMed ID: 38231289
    [Abstract] [Full Text] [Related]

  • 28. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer.
    Holdenrieder S, von Pawel J, Dankelmann E, Duell T, Faderl B, Markus A, Siakavara M, Wagner H, Feldmann K, Hoffmann H, Raith H, Nagel D, Stieber P.
    Clin Cancer Res; 2008 Dec 01; 14(23):7813-21. PubMed ID: 19047109
    [Abstract] [Full Text] [Related]

  • 29. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer.
    Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Kameyama M, Suehiro S.
    Ann Thorac Surg; 2007 Jan 01; 83(1):216-21. PubMed ID: 17184666
    [Abstract] [Full Text] [Related]

  • 30. Cyfra 21-1 as a serum tumor marker for follow-up of patients with laryngeal and hypopharyngeal squamous cell carcinoma.
    Al-Shagahin H, Alkotyfan K, Müller HH, Sesterhenn AM, Werner JA.
    Anticancer Res; 2009 Aug 01; 29(8):3421-5. PubMed ID: 19661367
    [Abstract] [Full Text] [Related]

  • 31. CYFRA 21-1 in non-small cell lung cancer--standardisation and application during diagnosis.
    Pavićević R, Bubanović G, Franjević A, Stancić-Rokotov D, Samarzija M.
    Coll Antropol; 2008 Jun 01; 32(2):485-98. PubMed ID: 18756899
    [Abstract] [Full Text] [Related]

  • 32. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E, Laçin M, Asal K, Ceylan A, Köybaşioğlu A, Ileri F, Uslu SS.
    Kulak Burun Bogaz Ihtis Derg; 2004 Jun 01; 12(1-2):23-30. PubMed ID: 16010093
    [Abstract] [Full Text] [Related]

  • 33. Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer.
    Nakata B, Takashima T, Ogawa Y, Ishikawa T, Hirakawa K.
    Br J Cancer; 2004 Aug 31; 91(5):873-8. PubMed ID: 15280913
    [Abstract] [Full Text] [Related]

  • 34. Serum tumour markers in patients with chronic kidney disease.
    Xiaofang Y, Yue Z, Xialian X, Zhibin Y.
    Scand J Clin Lab Invest; 2007 Aug 31; 67(6):661-7. PubMed ID: 17852811
    [Abstract] [Full Text] [Related]

  • 35. Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
    Muley T, Fetz TH, Dienemann H, Hoffmann H, Herth FJ, Meister M, Ebert W.
    Lung Cancer; 2008 Jun 31; 60(3):408-15. PubMed ID: 18083270
    [Abstract] [Full Text] [Related]

  • 36. [Contribution of serum Cyfra 21-1 in nasopharyngeal carcinoma in Tunisia].
    Jmal A, Boussen H, Abdennebi M, Gara S, Harzallah L, Gritli S, Ladgham A, Guemira F, Ghanem A.
    Bull Cancer; 2004 Apr 31; 91(4):369-72. PubMed ID: 15242321
    [Abstract] [Full Text] [Related]

  • 37. Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma.
    Pariente JL, Bordenave L, Michel P, Latapie MJ, Ducassou D, Le Guillou M.
    J Urol; 1997 Aug 31; 158(2):338-41. PubMed ID: 9224298
    [Abstract] [Full Text] [Related]

  • 38. Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma.
    Rodríguez CA, Cruz JJ, Martín T, Gómez A, Olaverri A, Hernández M.
    Cancer; 2002 Aug 01; 95(3):670-1; author reply 671. PubMed ID: 12209762
    [No Abstract] [Full Text] [Related]

  • 39. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
    Wójcik E, Kulpa JK, Sas-Korczyńska B, Korzeniowski S, Jakubowicz J.
    Anticancer Res; 2008 Aug 01; 28(5B):3027-33. PubMed ID: 19031951
    [Abstract] [Full Text] [Related]

  • 40. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY, Lui WY, Chi CW, Chau YP, Li AF, Kao HL, Wu CW.
    Eur J Surg Oncol; 2008 Mar 01; 34(3):333-8. PubMed ID: 17218078
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.